Fagoterapia frente a infecciones por Staphylococcus aureus meticilino resistente en ratones
Tamariz, Jesús H; Lezameta, Lizet; Guerra, Humberto.
Rev. peru. med. exp. salud publica
; 31(1): 69-77, ene.-mar. 2014. ilus, tab
Artículo en Español | LILACS, LIPECS | ID: lil-705967
Documentos relacionados
[Phagotherapy faced with Staphylococcus aureus methicilin resistant infections in mice].
Therapeutic potential of bacteriophage endolysins for infections caused by Gram-positive bacteria.
Host and pathogen response to bacteriophage engineered against Mycobacterium abscessus lung infection.
Descriptive evaluation of patients receiving one-time intravenous vancomycin doses at a large academic medical center emergency department.
Proteomic analysis revealed the biofilm-degradation abilities of the bacteriophage UPMK_1 and UPMK_2 against Methicillin-resistant Staphylococcus aureus.
Bacteriophages and their derived enzymes as promising alternatives for the treatment of Acinetobacter baumannii infections.
Overcoming bacteriophage insensitivity in Staphylococcus aureus using clindamycin and azithromycinat subinhibitory concentrations.
Antibacterial effects of single phage and phage cocktail against multidrug-resistant Klebsiella pneumoniae isolated from diabetic foot ulcer.
Treatment optimization by monitoring vancomycin concentration in the serum and cerebrospinal fluid in a child with cystoperitoneal shunt-related infection caused by methicillin-resistant Staphylococcus aureus: a case report and literature review.
The evaluation of five commercial bacteriophage cocktails against methicillin-resistant Staphylococcus aureus isolated from nasal swab samples.